Blog
ICH Q12: Post-Approval Change Management for Pharmaceutical Products Explained
TLDR ICH Q12, adopted at ICH Step 4 in November 2019, gives pharmaceutical manufacturers a globally harmonized framework for managing
Multi-Site QMS Management: Harmonizing Quality Across Global Facilities Under FDA and ISO
Manage a QMS across multiple global sites under FDA QMSR and ISO 13485. Learn harmonization strategies, common failure modes, and
How to Scale Your eQMS Without Scaling Your Costs
TLDR Growing life sciences companies often discover their eQMS pricing model punishes them for success. Per-user seats, per-module fees, per-environment
Legacy QMS vs. Cloud QMS: What Quality Teams Are Getting Wrong About the Switch
Most quality leaders evaluating a move from their legacy QMS to a cloud platform are working with outdated assumptions. Those
AI in GxP Systems: FDA’s 2026 Expectations When Your QMS Uses Artificial Intelligence
As AI tools embed into eQMS platforms and quality workflows, FDA’s 2026 expectations for computer system validation and data integrity
Human Factors Engineering in Medical Devices: FDA’s May 2026 Final Guidance Requirements
FDA finalized its guidance on human factors information in medical device marketing submissions on May 29, 2026. Learn what changed,